Fundz

Who to call at Maypharm Ltd, and when

Fundz watches for the moments Maypharm Ltd starts buying, and tells you who to reach.

  • An alert the day Maypharm Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Maypharm Ltd, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

LaunchMaypharm Co., Ltd. Launches Hyalmass Aqua-Exosome for Advanced Skin Hydration and Regeneration.

Dec 30, 2024
South KoreaManufacturingBiotechnologyHealth CareBeautyCosmetics

Product Description

Maypharm Co., Ltd. has introduced Hyalmass Aqua-Exosome, a new hybrid mesotherapy filler aimed at enhancing skin hydration and revitalization. This innovative product combines hyaluronic acid, exosomes, and PDRN to provide significant improvements in skin health.

Company Information

Company

Maypharm Ltd

Location

South Korea

About

Maypharm Co., Ltd. is a leading innovator in medical and dermo-cosmetic products. The company is committed to pushing the boundaries of aesthetic technology, continuously striving to deliver transformative results for customers. It focuses on innovation, excellence, and customer satisfaction in the field of cosmetic medicine. Maypharm introduces groundbreaking products like Hyalmass Aqua-Exosome to redefine skin hydration and regeneration.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Maypharm Ltd ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Maypharm Ltd's next move

Learn about Strategic plan

Product Launch Insights

What this usually means
Market expansion signals
New product launches often coincide with market expansion initiatives

Maypharm Ltd shipped something new. Fundz reads product launches, trademark filings and hiring together.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.